PubMed:31655933 / 645-1054 JSONTXT

{"project":"sonoma2","denotations":[{"id":"T50","span":{"begin":7,"end":10},"obj":"DISEASE"},{"id":"T51","span":{"begin":9,"end":13},"obj":"DISEASE"},{"id":"T52","span":{"begin":25,"end":39},"obj":"DISEASE"},{"id":"T53","span":{"begin":28,"end":42},"obj":"MPA"},{"id":"T54","span":{"begin":76,"end":85},"obj":"POSREG"},{"id":"T55","span":{"begin":86,"end":90},"obj":"GENE"},{"id":"T56","span":{"begin":91,"end":97},"obj":"MPA"},{"id":"T57","span":{"begin":168,"end":184},"obj":"DISEASE"},{"id":"T58","span":{"begin":171,"end":187},"obj":"MPA"},{"id":"T59","span":{"begin":222,"end":226},"obj":"GENE"},{"id":"T60","span":{"begin":227,"end":233},"obj":"MPA"},{"id":"T61","span":{"begin":234,"end":244},"obj":"REG"},{"id":"T62","span":{"begin":250,"end":259},"obj":"MPA"},{"id":"T63","span":{"begin":287,"end":290},"obj":"MPA"},{"id":"T64","span":{"begin":319,"end":323},"obj":"GENE"},{"id":"T65","span":{"begin":324,"end":334},"obj":"REG"},{"id":"T66","span":{"begin":340,"end":349},"obj":"MPA"},{"id":"T67","span":{"begin":376,"end":385},"obj":"MPA"}],"relations":[{"id":"R89","pred":"ThemeOf","subj":"T51","obj":"T53"},{"id":"R90","pred":"ThemeOf","subj":"T51","obj":"T54"},{"id":"R91","pred":"ThemeOf","subj":"T51","obj":"T56"},{"id":"R92","pred":"ThemeOf","subj":"T53","obj":"T54"},{"id":"R93","pred":"ThemeOf","subj":"T56","obj":"T54"},{"id":"R94","pred":"ThemeOf","subj":"T55","obj":"T54"},{"id":"R95","pred":"ThemeOf","subj":"T55","obj":"T56"},{"id":"R102","pred":"ThemeOf","subj":"T62","obj":"T65"},{"id":"R103","pred":"ThemeOf","subj":"T63","obj":"T61"},{"id":"R104","pred":"ThemeOf","subj":"T63","obj":"T65"},{"id":"R105","pred":"ThemeOf","subj":"T64","obj":"T61"},{"id":"R106","pred":"ThemeOf","subj":"T64","obj":"T65"},{"id":"R107","pred":"ThemeOf","subj":"T66","obj":"T65"},{"id":"R108","pred":"ThemeOf","subj":"T67","obj":"T65"},{"id":"R96","pred":"ThemeOf","subj":"T58","obj":"T54"},{"id":"R97","pred":"ThemeOf","subj":"T59","obj":"T60"},{"id":"R98","pred":"ThemeOf","subj":"T59","obj":"T61"},{"id":"R99","pred":"ThemeOf","subj":"T60","obj":"T61"},{"id":"R100","pred":"ThemeOf","subj":"T62","obj":"T60"},{"id":"R101","pred":"ThemeOf","subj":"T62","obj":"T61"}],"text":"RESULTS: JSLE patients with active disease (SLEDAI-2K\u003e 4) had significantly increased sMer levels compared with healthy controls (median 8.4 vs. 6.0 ng/mL, p = 0.009) and inactive disease patients (5.2 ng/mL, p = 0.0003). sMer levels correlated with SLEDAI-2K (r = 0.44; p = 0.0004) and ESR (r = 0.24; p = 0.04), while sAxl correlated with SLEDAI-2K (r = 0.33; p = 0.008) and C4 levels (r = - 0.24; p = 0.04)."}

{"project":"Inflammaging","denotations":[{"id":"T7","span":{"begin":0,"end":409},"obj":"Sentence"},{"id":"T7","span":{"begin":0,"end":409},"obj":"Sentence"}],"text":"RESULTS: JSLE patients with active disease (SLEDAI-2K\u003e 4) had significantly increased sMer levels compared with healthy controls (median 8.4 vs. 6.0 ng/mL, p = 0.009) and inactive disease patients (5.2 ng/mL, p = 0.0003). sMer levels correlated with SLEDAI-2K (r = 0.44; p = 0.0004) and ESR (r = 0.24; p = 0.04), while sAxl correlated with SLEDAI-2K (r = 0.33; p = 0.008) and C4 levels (r = - 0.24; p = 0.04)."}